PACE Part D Choice Act of 2023
S 1703, the PACE Part D Choice Act of 2023, gives Medicare beneficiaries enrolled in PACE programs (who do not receive Medicaid) the option to choose an external prescription drug plan starting in 2025. It requires that any external plan chosen must have equal or lower estimated out-of-pocket costs and comparable federal subsidies compared to the PACE program's own drug plan. PACE programs must provide enrollment information and assistance to members, monitor drug use for those who switch, and share claims data with the external drug plan provider. This bill directly affects PACE enrollees who are Medicare-only beneficiaries seeking prescription drug coverage.
Bill status
in committee
1 of 4 stages cleared
Introduction
May 2023
Committee Review
Floor Vote
President
Introduced May 18, 2023
Last action May 18, 2023
Floor votes
How they voted
No floor votes recorded yet.
Full legislative history
Actions timeline
Total actions
2
Key actions
0
Committee
1
May 18, 2023
Committee
Read twice and referred to the Committee on Finance.
upper
May 18, 2023
Introduced
Introduced in Senate
upper
1 primary · 2 co-sponsors
Sponsors
Role
Legislator
Party
State
District
P
Thomas R. Carper
DDemocratic
Co
Bill Cassidy
RRepublican
Co
Gary C. Peters
DDemocratic
Ask Maddy
·
AI policy assistant
Ask Maddy about S 1703
Scope: US
Hi! I can help you understand S 1703. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline